Hypoxia-reoxygenation-induced endothelial barrier failure: Role of RhoA, Rac1 and myosin light chain kinase

Journal of Physiology

Volumn 591, Issue 2, 2013, Pages 461-473

  Aslam, Muhammad ^a   Schluter, Klaus Dieter ^a   Rohrbach, Susanne ^a   Rafiq, Amir ^a   Nazli, Sabiha ^a   Piper, Hans Michael ^a   Noll, Thomas ^a   Schulz, Rainer ^a   Gündüz, Dursun ^b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ALBUMIN; CYCLIC AMP BINDING PROTEIN; MYOSIN LIGHT CHAIN KINASE; PROTEIN EPAC; RAC1 PROTEIN; RAP1 PROTEIN; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ACTIN FILAMENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL JUNCTION; CONTROLLED STUDY; DEPOLYMERIZATION; ENDOTHELIAL BARRIER; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPOXIA; MALE; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; STRESS FIBER;

ACTINS; ADHERENS JUNCTIONS; ANIMALS; ANTIGENS, CD; AORTA; CADHERINS; CALCIUM; CELL HYPOXIA; CYCLIC AMP; ENDOTHELIAL CELLS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; MYOSIN-LIGHT-CHAIN KINASE; PERMEABILITY; RAC1 GTP-BINDING PROTEIN; RATS; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STRESS FIBERS; SWINE; VASOCONSTRICTION;

EID: 84872371391     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.237834     Document Type: Article

References (33)

1. Alexander JS, Blaschuk OW & Haselton FR (1993). An N-cadherin-like protein contributes to solute barrier maintenance in cultured endothelium. J Cell Physiol 156, 610-618.
2. Aslam M, Gündüz D, Schuler D, Li L, Sharifpanah F, Sedding D, Piper HM & Noll T (2011). Intermedin induces loss of coronary microvascular endothelial barrier via derangement of actin cytoskeleton: role of RhoA and Rac1. Cardiovasc Res 92, 276-286.
3. Aslam M, Härtel FV, Arshad M, Gündüz D, Abdallah Y, Sauer H, Piper HM & Noll T (2010). cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Cardiovasc Res 87, 375-384.
4. Baumer Y, Drenckhahn D & Waschke J (2008). cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium. Histochem Cell Biol 129, 765-778.
5. Brown RC, Mark KS, Egleton RD & Davis TP (2004). Protection against hypoxia-induced blood-brain barrier disruption: changes in intracellular calcium. Am J Physiol Cell Physiol 286, C1045-C1052.
6. Dejana E, Orsenigo F & Lampugnani MG (2008). The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121, 2115-2122.
7. Gündüz D, Kasseckert SA, Härtel FV, Aslam M, Abdallah Y, Schäfer M, Piper HM, Noll T & Schäfer C (2006). Accumulation of extracellular ATP protects against acute reperfusion injury in rat heart endothelial cells. Cardiovasc Res 71, 764-773.
8. Hall A (1998). Rho GTPases and the actin cytoskeleton. Science 279, 509-514.
9. Ho KC, Leach JK, Eley K, Mikkelsen RB & Lin PS (2003). A simple method of producing low oxygen conditions with oxyrase for cultured cells exposed to radiation and tirapazamine. Am J Clin Oncol 26, e86-e91.
10. Huang Q, Xu W, Ustinova E, Wu M, Childs E, Hunter F & Yuan S (2003). Myosin light chain kinase-dependent microvascular hyperpermeability in thermal injury. Shock 20, 363-368.
11. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M & Narumiya S (2000). Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 57, 976-983.
12. Jung F, Haendeler J, Hoffmann J, Reissner A, Dernbach E, Zeiher AM & Dimmeler S (2002). Hypoxic induction of the hypoxia-inducible factor is mediated via the adaptor protein Shc in endothelial cells. Circ Res 91, 38-45.
13. Lampugnani MG, Corada M, Caveda L, Breviario F, Ayalon O, Geiger B & Dejana E (1995). The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, b-catenin, and a-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129, 203-217.
14. Maekawa M, Ishizaki T, Boku S, Watanabe N, Fujita A, Iwamatsu A, Obinata T, Ohashi K, Mizuno K & Narumiya S (1999). Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase. Science 285, 895-898.
15. 2+ mediates rac activation and adherens junction assembly in endothelial cells. J Biol Chem 280, 17320-17328.
16. Mehta D & Malik AB (2006). Signaling mechanisms regulating endothelial permeability. Physiol Rev 86, 279-367.
17. Noll T, Wozniak G, McCarson K, Hajimohammad A, Metzner HJ, Inserte J, Kummer W, Hehrlein FW & Piper HM (1999). Effect of factor XIII on endothelial barrier function. J Exp Med 189, 1373-1382.
18. Oshiro H, Kobayashi I, Kim D, Takenaka H, Hobson RW & Duran WN (1995). L-type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J Vasc Surg 22, 732-739.
19. 2+ release from the endoplasmic reticulum in cardiac endothelial cells. Cardiovasc Res 73, 164-171.
20. Pfeil U, Aslam M, Paddenberg R, Quanz K, Chang CL, Park JI, Gries B, Rafiq A, Faulhammer P, Goldenberg A, Papadakis T, Noll T, Hsu SY, Weissmann N & Kummer W (2009). Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol 297, L837-L845.
21. Robin E, Guzy RD, Loor G, Iwase H, Waypa GB, Marks JD, Hoek TL & Schumacker PT (2007). Oxidant stress during simulated ischemia primes cardiomyocytes for cell death during reperfusion. J Biol Chem 282, 19133-19143.
22. 2+ signalling and PKCa activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 533, 433-445.
23. Shasby DM & Shasby SS (1986). Effects of calcium on transendothelial albumin transfer and electrical resistance. J Appl Physiol 60, 71-79.
24. Sica DA (2003). Calcium channel blocker-related periperal edema: can it be resolved J Clin Hypertens (Greenwich) 5, 291-294, 297.
25. 2+ entry induces RhoA activation and resultant endothelial cell shape change in response to thrombin. J Biol Chem 282, 7833-7843.
26. Stocker R & Keaney JF Jr. (2004). Role of oxidative modifications in atherosclerosis. Physiol Rev 84, 1381-1478.
27. Stocker R & Keaney JF Jr. (2005). New insights on oxidative stress in the artery wall. J Thromb Haemost 3, 1825-1834.
28. Taherzadeh M, Das AK & Warren JB (1998). Nifedipine increases microvascular permeability via a direct local effect on postcapillary venules. Am J Physiol Heart Circ Physiol 275, H1388-H1394.
29. Taherzadeh M & Warren JB (1997). Comparison of diltiazem and verapamil on rat microvascular permeability. Microvasc Res 54, 206-213.
30. Vandenbroucke E, Mehta D, Minshall R & Malik AB (2008). Regulation of endothelial junctional permeability. Ann N Y Acad Sci 1123, 134-145.
31. Waschke J, Curry FE, Adamson RH & Drenckhahn D (2005). Regulation of actin dynamics is critical for endothelial barrier functions. Am J Physiol Heart Circ Physiol 288, H1296-H1305.
32. Wojciak-Stothard B, Potempa S, Eichholtz T & Ridley AJ (2001). Rho and Rac but not Cdc42 regulate endothelial cell permeability. J Cell Sci 114, 1343-1355.
33. Wojciak-Stothard B & Ridley AJ (2002). Rho GTPases and the regulation of endothelial permeability. Vascul Pharmacol 39, 187-199.